Clover Health Investments Statistics
Total Valuation
CLOV has a market cap or net worth of $1.89 billion. The enterprise value is $1.63 billion.
Important Dates
The next confirmed earnings date is Wednesday, November 6, 2024, after market close.
| Earnings Date | Nov 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CLOV has 497.47 million shares outstanding. The number of shares has increased by 1.50% in one year.
| Shares Outstanding | 497.47M |
| Shares Change (YoY) | +1.50% |
| Shares Change (QoQ) | +1.81% |
| Owned by Insiders (%) | 21.07% |
| Owned by Institutions (%) | 14.92% |
| Float | 391.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.88 |
| Forward PS | 1.35 |
| PB Ratio | 5.77 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.78 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.69, with a Debt / Equity ratio of 0.01.
| Current Ratio | 1.69 |
| Quick Ratio | 1.61 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -36.85% and return on invested capital (ROIC) is -18.90%.
| Return on Equity (ROE) | -36.85% |
| Return on Assets (ROA) | -6.50% |
| Return on Capital (ROIC) | -18.90% |
| Revenue Per Employee | $3.79M |
| Profits Per Employee | -$224,100 |
| Employee Count | 552 |
| Asset Turnover | 2.16 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +312.20% in the last 52 weeks. The beta is 2.14, so CLOV's price volatility has been higher than the market average.
| Beta (5Y) | 2.14 |
| 52-Week Price Change | +312.20% |
| 50-Day Moving Average | 3.27 |
| 200-Day Moving Average | 1.61 |
| Relative Strength Index (RSI) | 55.59 |
| Average Volume (20 Days) | 9,525,166 |
Short Selling Information
The latest short interest is 25.51 million, so 5.13% of the outstanding shares have been sold short.
| Short Interest | 25.51M |
| Short Previous Month | 25.80M |
| Short % of Shares Out | 5.13% |
| Short % of Float | 6.51% |
| Short Ratio (days to cover) | 3.53 |
Income Statement
In the last 12 months, CLOV had revenue of $2.09 billion and -$123.70 million in losses. Loss per share was -$0.25.
| Revenue | 2.09B |
| Gross Profit | 319.02M |
| Operating Income | -100.53M |
| Pretax Income | -123.70M |
| Net Income | -123.70M |
| EBITDA | -99.85M |
| EBIT | -100.53M |
| Loss Per Share | -$0.25 |
Full Income StatementBalance Sheet
The company has $379.05 million in cash and $4.01 million in debt, giving a net cash position of $250.76 million or $0.50 per share.
| Cash & Cash Equivalents | 379.05M |
| Total Debt | 4.01M |
| Net Cash | 250.76M |
| Net Cash Per Share | $0.50 |
| Equity (Book Value) | 324.89M |
| Book Value Per Share | 0.65 |
| Working Capital | 225.07M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$177.38 million and capital expenditures -$821,000, giving a free cash flow of -$178.21 million.
| Operating Cash Flow | -177.38M |
| Capital Expenditures | -821,000 |
| Free Cash Flow | -178.21M |
| FCF Per Share | -$0.36 |
Full Cash Flow StatementMargins
Gross margin is 15.27%, with operating and profit margins of -4.81% and -5.92%.
| Gross Margin | 15.27% |
| Operating Margin | -4.81% |
| Pretax Margin | -5.78% |
| Profit Margin | -5.92% |
| EBITDA Margin | -4.78% |
| EBIT Margin | -4.81% |
| FCF Margin | -10.51% |